Vycor Medical Inc
VYCO· OTC
VYCOVycor Medical Inc
Released May 15, 2024, during market hours
10-Q filed May 15, 2024, 45 days after period end · 0001493152-24-019658
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|
| Revenue | $336.97K | $360.99K | $313.83K | $295.75K |
| Net Income | -$30.61K | $6.86K | -$74.55K | -$242.92K |
| EPS Diluted | -$0.01 |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| $0.00 |
| — |
| -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
